Antibiotic exposure during the first 6 months of life and weight gain during childhood

JAMA - Journal of the American Medical Association

Volumn 315, Issue 12, 2016, Pages 1258-1265

  Gerber, Jeffrey S ^a,b   Bryan, Matthew ^b   Ross, Rachael K ^a   Daymont, Carrie ^c   Parks, Elizabeth P ^a,b   Localio, A Russell ^b   Grundmeier, Robert W ^a,b   Stallings, Virginia A ^a,b   Zaoutis, Theoklis E ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MACROLIDE; ANTIINFECTIVE AGENT;

ARTICLE; BIRTH WEIGHT; CHILD GROWTH; FEMALE; FOLLOW UP; GESTATIONAL AGE; GROWTH CURVE; HUMAN; INFANT; LONGITUDINAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TWINS; UNITED STATES; WEIGHT CHANGE; WEIGHT GAIN; AGE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; DIZYGOTIC TWINS; DRUG EFFECTS; GROWTH; MULTICENTER STUDY; PHYSIOLOGY; PRESCHOOL CHILD; PRIMARY PREVENTION; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; ANTI-BACTERIAL AGENTS; BIRTH WEIGHT; CHILD; CHILD, PRESCHOOL; DELAWARE; FEMALE; GESTATIONAL AGE; GROWTH; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; MATCHED-PAIR ANALYSIS; NEW JERSEY; PENNSYLVANIA; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; TWINS, DIZYGOTIC; WEIGHT GAIN;

EID: 84962292841     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.2395     Document Type: Article

References (30)

1. Chai G, Governale L, McMahon AW, Trinidad JP, Staffa J, Murphy D. Trends of outpatient prescription drug utilization in US children, 2002-2010. Pediatrics. 2012;130(1):23-31.
2. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009; 302(7):758-766.
3. Furuya EY, Lowy FD. Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol. 2006;4(1):36-45.
4. Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47(6):735-743.
5. Butaye P, Devriese LA, Haesebrouck F. Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria. Clin Microbiol Rev. 2003;16 (2):175-188.
6. Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007;1(1):56-66.
7. Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488(7413):621-626.
8. Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341 (6150):1241214.
9. Ajslev TA, Andersen CS, Gamborg M, Sørensen TI, Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes (Lond). 2011;35(4):522-529.
10. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes (Lond). 2013;37(1):16-23.
11. Bailey LC, Forrest CB, Zhang P, Richards TM, Livshits A, DeRusso PA. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr. 2014;168(11):1063-1069.
12. Saari A, Virta LJ, Sankilampi U, Dunkel L, Saxen H. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics. 2015;135(4):617-626.
13. Dawson NV, Weiss R. Dichotomizing continuous variables in statistical analysis: a practice to avoid. Med Decis Making. 2012;32(2):225-226.
14. Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr. 2003; 3:13.
15. Feudtner C, Christakis DA, Connell FA. Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980-1997. Pediatrics. 2000;106(1 Pt 2):205-209.
16. Cox LM, Yamanishi S, Sohn J, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158(4):705-721.
17. Kronmal RA. Spurious correlation and the fallacy of the ratio standard revisited. J R Stat Soc Ser A Stat Soc. 1993;156(3):379-392.
18. Daymont C, Zabel M, Feudtner C, Rubin DM. The test characteristics of head circumference measurements for pathology associated with head enlargement: a retrospective cohort study. BMC Pediatr. 2012;12:9.
19. Gerber JS, Prasad PA, Localio AR, et al. Racial differences in antibiotic prescribing by primary care pediatricians. Pediatrics. 2013;131(4):677-684.
20. Bryan M, Heagerty PJ. Direct regression models for longitudinal rates of change. Stat Med. 2014;33(12):2115-2136.
21. Naumova EN, Must A, Laird NM. Tutorial in biostatistics: evaluating the impact of "critical periods" in longitudinal studies of growth using piecewise mixed effects models. Int J Epidemiol. 2001;30(6):1332-1341.
22. Yang S, Tilling K, Martin R, Davies N, Ben-Shlomo Y, Kramer MS. Pre-natal and post-natal growth trajectories and childhood cognitive ability and mental health. Int J Epidemiol. 2011;40(5):1215-1226.
23. Fitzmaurice G, Laird NM, Ware J. Applied Longitudinal Analysis. 2nd ed. New York, NY: John Wiley & Sons; 2011.
24. Fitzmaurice G, Davidian M, Verbeke G, Molenberghs G. Longitudinal Data Analysis. Boca Raton, FL: Chapman & Hall/CRC; 2009.
25. Grundmeier RW, Song L, Ramos MJ, et al. Imputing missing race/ethnicity in pediatric electronic health records: reducing bias with use of US Census location and surname data. Health Serv Res. 2015;50(4):946-960.
26. Goodman SN, Berlin JA. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med. 1994;121(3):200-206.
27. Gough EK, Moodie EE, Prendergast AJ, et al. The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials. BMJ. 2014;348:g2267.
28. Smith MI, Yatsunenko T, Manary MJ, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science. 2013;339(6119):548-554.
29. Senn S, Julious S. Measurement in clinical trials: a neglected issue for statisticians? Stat Med. 2009; 28(26):3189-3209.
30. Gerber JS, Prasad PA, Russell Localio A, et al. Variation in antibiotic prescribing across a pediatric primary care network. J Pediatric Infect Dis Soc. 2015;4(4):297-304.